Literature DB >> 11224403

Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition.

E.C. Warburton1, S.N. Mitchell, M.H. Joseph.   

Abstract

Repeated amphetamine treatment results in sensitisation both of its behavioural effects, and of its dopamine (DA)-releasing effects on which the former largely depend. Understanding the nature of the sensitised response may help to explain behaviours which emerge only with repeated treatment, such as particular stereotypies and effects on social behaviour in animals, and links between these effects and the emergence of dependence and psychotic symptoms in humans. We show here that a single pretreatment with amphetamine (1mg/kg) is sufficient to sensitise the locomotor response to amphetamine challenge (1mg/kg) 24h later. We have used in vivo microdialysis in the nucleus accumbens in unrestrained rats to demonstrate a corresponding potentiation in the DA response; the marked increase in accumbens dialysate DA following amphetamine (to 427% of basal) was significantly potentiated (to 675% of basal) by the pretreatment, without any alteration in the basal DA. There was also no change in the expected reduction in DA metabolites. Replacement of perfusate calcium by magnesium left the response to acute amphetamine challenge substantially unaffected, as expected from previous reports; however, the potentiation of the DA response by amphetamine pretreatment was prevented. Similarly the potentiated response was attenuated by administration of ondansetron, a 5HT-3 antagonist, (0.01mg/kg) before each amphetamine treatment. The ability of amphetamine to disrupt latent inhibition (L1), which is also disrupted in acute schizophrenia, has been suggested to provide a model of schizophrenia linking underlying cognitive deficits with the DA theory of the disorder. Since LI is disrupted by two systemic administrations of amphetamine 24h apart, but not by one, the present results are consistent with the concept that it is the calcium, and hence impulse, dependence of increased accumbal DA release, rather than its magnitude, which is critical for the disruption of LI.

Entities:  

Year:  1996        PMID: 11224403

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  11 in total

1.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition.

Authors:  E Diaz; J Medellín; N Sánchez; J P Vargas; J C López
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

3.  Repeated cocaine modifies the mechanism by which amphetamine releases dopamine.

Authors:  R C Pierce; P W Kalivas
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

4.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

5.  Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles.

Authors:  L Kantor; G H Hewlett; M E Gnegy
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

Review 6.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

7.  Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.

Authors:  Emily M Jutkiewicz; Danielle M Nicolazzo; Myung N Kim; Margaret E Gnegy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

8.  A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition.

Authors:  N A Schmajuk; J A Gray; J A Larrauri
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

9.  Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat.

Authors:  C W Stevenson; Alain Gratton
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

10.  Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.

Authors:  L M McDonald; P M Moran; G N Vythelingum; M H Joseph; J D Stephenson; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.